Gene Neighbors May Have Taken Turns Battling Retroviruses

Main Category: Genetics
Also Included In: Infectious Diseases / Bacteria / Viruses;  HIV / AIDS
Article Date: 20 Dec 2007 - 17:00 PDT

email to a friend   printer friendly   view / write opinions

A cluster of antiviral genes in humans has likely battled retroviral invasions for millions of years. New research by scientists at the Fred Hutchinson Cancer Center now finds that in addition to the previously identified TRIM5 gene that can defend against retroviruses like HIV, a related gene right next door, called TRIM22, may have participated in antiviral defense.

These findings, published Dec. 21 in PLoS Pathogens, show that both TRIM5 and TRIM22 exhibit the hallmarks of rapid evolutionary adaptation (positive selection) required to defeat new retroviral invasions. However, their genetic proximity has resulted in positive selection in either TRIM5 or TRIM22, but not both. This suggests that at various times over the past millions of years, both genes alternately have defended against retroviruses.

"The identification of novel antiviral genes is important to understanding the genetic basis of differential human susceptibility to viral diseases," said co-author Sarah Sawyer.

The recent identification of TRIM5 as one of the genetic means that protect rhesus monkeys against HIV infection has opened up a new area of research in HIV biology. Previous work had shown that TRIM5 has been locked in genetic conflict with retroviruses throughout most of primate evolution, characterized by a higher than expected rate of amino acid change, referred to as positive selection.

The new study now suggests that one of the closest genes in evolutionary age and genetic proximity, TRIM22, also has the same hallmarks. However, unlike TRIM5, TRIM22 did not have antiviral activity against any modern viruses tested. "We are at an interesting point in this kind of research," co-author Michael Emerman said. "Instead of looking at which unknown antiviral gene protected against a given virus, we now need to ask which unknown virus may have been defeated by a given candidate antiviral gene. It is possible that this virus no longer exists today, but may have only existed in our evolutionary past."

TRIM5 and TRIM22 also appear to have discordant evolution in other mammals. Whereas the cow genome contains an expansion of TRIM5 genes and no TRIM22 gene, the dog genome encodes TRIM22 but has lost TRIM5. In spite of this evolutionary discordance, amino acid residues in TRIM22 found to be under positive selection are in remarkable proximity to those found previously to be critically important for TRIM5's antiviral activity. Thus, despite an ancient separation of the TRIM5 and TRIM22 genes, the "rules" by which they might combat viruses appear to be constant.

"This research was conducted via computer analysis and in tissue-culture cells and has not yet been tested in model organisms. Nonetheless, the evolutionary means to identify other potential antiviral TRIM genes in the human genome may identify novel candidates for therapeutic intervention," co-author Harmit Malik said.

Grants from amfAR (The Foundation for AIDS Research), the National Institutes of Health, the Searle Scholars Program and the Burroughs Wellcome Fund supported this research.

Citation: Sawyer SL, Emerman M, Malik HS (2007) Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog 3(12): e197. doi:10.1371/journal.ppat.0030197
Please click here
(link will go live on Friday, December 21, 2007)

Disclaimer

This press release refers to an upcoming article in PLoS Pathogens. The release is provided by the article authors and/or their institutions. Any opinions expressed in these releases or articles are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.

About PLoS Pathogens

PLoS Pathogens publishes outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms. All works published in PLoS Pathogens are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

http://www.plospathogens.org

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource.

Public Library of Science
185 Berry Street, Suite 3100
San Francisco, CA 94107
USA